BBHC
TTRX

Brown Brothers Harriman & Co’s Turn Therapeutics TTRX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Hold
23,688
– – ﹤0.01% 896
2026
Q1 		$75.8K Hold
23,688
– – ﹤0.01% 984
2025
Q4 		$93.3K Buy
+23,688
New +$98.7K ﹤0.01% 919

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return

Brown Brothers Harriman & Co's TTRX Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Turn Therapeutics (TTRX) position steady in Q2 2026 at 23,688 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Brown Brothers Harriman & Co first reported a position in TTRX in Q4 2025 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Brown Brothers Harriman & Co held 23,688 shares of Turn Therapeutics worth $173K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Turn Therapeutics share count unchanged in Q2 2026.
  • Turn Therapeutics made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #896 holding.
  • Brown Brothers Harriman & Co first reported a position in Turn Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.